Learn More
The initial genome-scale reconstruction of the metabolic network of Escherichia coli K-12 MG1655 was assembled in 2000. It has been updated and periodically released since then based on new and curated genomic and biochemical knowledge. An update has now been built, named iJO1366, which accounts for 1366 genes, 2251 metabolic reactions, and 1136 unique(More)
Enzymes are thought to have evolved highly specific catalytic activities from promiscuous ancestral proteins. By analyzing a genome-scale model of Escherichia coli metabolism, we found that 37% of its enzymes act on a variety of substrates and catalyze 65% of the known metabolic reactions. However, it is not apparent why these generalist enzymes remain.(More)
BACKGROUND One of the most challenging problems in mining gene expression data is to identify how the expression of any particular gene affects the expression of other genes. To elucidate the relationships between genes, an association rule mining (ARM) method has been applied to microarray gene expression data. However, a conventional ARM method has a(More)
MOTIVATION For the early detection of cancer, highly sensitive and specific biomarkers are needed. Particularly, biomarkers in bio-fluids are relatively more useful because those can be used for non-biopsy tests. Although the altered metabolic activities of cancer cells have been observed in many studies, little is known about metabolic biomarkers for(More)
Detection of somatic variation using sequence from disease-control matched data sets is a critical first step. In many cases including cancer, however, it is hard to isolate pure disease tissue, and the impurity hinders accurate mutation analysis by disrupting overall allele frequencies. Here, we propose a new method, Virmid, that explicitly determines the(More)
Altered metabolism in cancer cells has been viewed as a passive response required for a malignant transformation. However, this view has changed through the recently described metabolic oncogenic factors: mutated isocitrate dehydrogenases (IDH), succinate dehydrogenase (SDH), and fumarate hydratase (FH) that produce oncometabolites that competitively(More)
BACKGROUND Lymph node invasion is one of the most powerful clinical factors in cancer prognosis. However, molecular level signatures of their correlation are remaining poorly understood. Here, we propose a new approach, monotonically expressed gene analysis (MEGA), to correlate transcriptional patterns of lymph node invasion related genes with clinical(More)
MOTIVATION Finding somatic mutations from massively parallel sequencing data is becoming a standard process in genome-based biomedical studies. There are a number of robust methods developed for detecting somatic single nucleotide variations However, detection of somatic copy number alteration has been substantially less explored and remains vulnerable to(More)
Verifying the proteins that are targeted by compounds of natural herbs will help select natural herb-based drug candidates. However, this entails a great deal of effort to clarify the interaction throughout <i>in vitro or in vivo</i> experiments. In this light, <i>in silico</i> prediction of the interactions between compounds and target proteins can help(More)
The survival of patients with breast cancer is highly sporadic, from a few months to more than 15 years. Recently, the large-scale gene expression profiling of tumors has been used as a promising means of predicting prognosis factors. In this study, we used large-scale gene expression datasets of tumors to identify prognostic factors in breast cancer. We(More)